Related Experiment Video
Updated: Jun 7, 2026

Prospecting Microbial Strains for Bioremediation and Probiotics Development for Metaorganism Research and Preservation
Published on: October 31, 2019
The expanding role of marine microbes in pharmaceutical development
Amanda L Waters1, Russell T Hill, Allen R Place
1Department of Pharmacognosy, The University of Mississippi, University, MS 38677, USA.
Abstract:
Marine microbes have received growing attention as sources of bioactive metabolites and offer a unique opportunity to both increase the number of marine natural products in clinical trials as well as expedite their development. This review focuses specifically on those molecules currently in the clinical pipeline that are established or highly likely to be produced by bacteria based on expanding circumstantial evidence. We also include an example of how compounds from harmful algal blooms may yield both tools for measuring environmental change as well as leads for pharmaceutical development. An example of the karlotoxin class of compounds isolated from the dinoflagellate Karlodinium veneficum reveals a significant environmental impact in the form of massive fish kills, but also provides opportunities to construct new molecules for the control of cancer and serum cholesterol assisted by tools associated with rational drug design.
Related Concept Videos
Marine Microbial Ecology
Microorganisms in Medicine and Therapeutics
Environmental Applications of Microorganisms
Deep Sea Microbial Ecology
Microbial Bioremediation of Hydrocarbons
Microbial Wastewater Treatment

